Dr. Mukund G. Dole
Claim this profileDayton Children's Hospital
Expert in Tumors
Expert in Brain Tumor
53 reported clinical trials
105 drugs studied
About Mukund G. Dole
Education:
- Graduated from the University of Bombay, India.
- Completed Residency in General Pediatrics at Louisiana State University Medical Center.
- Undertook Fellowships in Pediatric Hematology/Oncology at both Louisiana State University Medical Center and the University of Michigan.
Experience:
- Currently serves as a pediatric hematologist-oncologist at Dayton Children's Hospital.
- Holds the position of Associate Professor of Pediatrics at Boonshoft School of Medicine, Wright State University.
- Acts as the program director of the West Central Ohio Comprehensive Sickle Cell Center.
- Specializes in sickle cell disease and related hemoglobin disorders, actively participating in COG clinical trials for pediatric cancer.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Mukund G. Dole is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Mukund G. Dole
Clinical Trial Related7 years of experience running clinical trials · Led 53 trials as a Principal Investigator · 23 Active Clinical TrialsTreatments Mukund G. Dole has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Vincristine Sulfate
- Doxorubicin Hydrochloride
- Methotrexate
Breakdown of trials Mukund G. Dole has run
Tumors
Brain Tumor
Lymphoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mukund G. Dole specialize in?
Mukund G. Dole focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Mukund G. Dole currently recruiting for clinical trials?
Yes, Mukund G. Dole is currently recruiting for 20 clinical trials in Dayton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Mukund G. Dole has studied deeply?
Yes, Mukund G. Dole has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Mukund G. Dole?
Apply for one of the trials that Mukund G. Dole is conducting.
What is the office address of Mukund G. Dole?
The office of Mukund G. Dole is located at: Dayton Children's Hospital, Dayton, Ohio 45404 United States. This is the address for their practice at the Dayton Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.